1 Min Read
Nov 15 (Reuters) - Johnson & Johnson
* Jannsen Inc says Health Canada has approved Tremfya for treatment of adult moderate to severe plaque Psoriasis Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.